Case Report: Bradycardia in Neonatal Lupus: Differential Diagnosis Between Atrioventricular Block and Premature Atrial Contractions with Block

Overview

Journal Front Pediatr

Specialty Pediatrics

Date 2024 Aug 15

PMID 39144470

Authors

Wei-Li Liu

Ying-Hsuan Peng

Affiliations

Soon will be listed here.

Abstract

Neonatal lupus may be associated with severe cardiac conduction problems, including high-degree or complete atrioventricular (AV) block, necessitating immediate pacemaker implantation during the neonatal period. However, cardiac manifestations of neonatal lupus may extend beyond AV block. Our case was a full-term female neonate, who presented with fetal arrhythmia and bradycardia with a heart rate of approximately 70-75 beats per minute after birth. Neonatal lupus was diagnosed later due to positive maternal and neonatal anti-SSA/Ro antibody. High-degree AV block was considered initially but bigeminy premature atrial contractions (PACs) with block was confirmed through a detailed evaluation of an electrocardiogram, which demonstrated unfixed PP intervals and fixed RR intervals. Atrial tachycardia (AT) developed when the neonate was 23 days old. The key point that differentiates high-degree AV block from PACs with block is the PP interval. The PP interval is fixed in high-degree AV block and unfixed in PACs with block. Careful differential diagnosis is required in neonates with bradycardia because it may lead to very different management. Our case presents a good illustration of why these arrhythmias need to be differentiated. Furthermore, our case may be the first of neonatal lupus with AT.

References

Popescu M, Dudu A, Jurcut C, Ciobanu A, Zagrean A, Panaitescu A . A Broader Perspective on Anti-Ro Antibodies and Their Fetal Consequences-A Case Report and Literature Review. Diagnostics (Basel). 2020; 10(7). PMC: 7399931. DOI: 10.3390/diagnostics10070478. View

Capone C, Buyon J, Friedman D, Frishman W . Cardiac manifestations of neonatal lupus: a review of autoantibody-associated congenital heart block and its impact in an adult population. Cardiol Rev. 2011; 20(2):72-6. PMC: 3275696. DOI: 10.1097/CRD.0b013e31823c808b. View

Buyon J, Clancy R, Friedman D . Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside. Nat Clin Pract Rheumatol. 2009; 5(3):139-48. DOI: 10.1038/ncprheum1018. View

Gryka-Marton M, Szukiewicz D, Teliga-Czajkowska J, Olesinska M . An Overview of Neonatal Lupus with Anti-Ro Characteristics. Int J Mol Sci. 2021; 22(17). PMC: 8431034. DOI: 10.3390/ijms22179281. View

Ban J . Neonatal arrhythmias: diagnosis, treatment, and clinical outcome. Korean J Pediatr. 2017; 60(11):344-352. PMC: 5725339. DOI: 10.3345/kjp.2017.60.11.344. View

Melim C, Pimenta J, Areias J . Congenital atrioventricular heart block: From diagnosis to treatment. Rev Port Cardiol. 2022; 41(3):231-240. DOI: 10.1016/j.repc.2019.09.021. View

Mikulski M, Well A, Shmorhun D, Fraser Jr C, Mery C, Fenrich Jr A . Pacemaker Management and In-Hospital Outcomes in Neonatal Congenital Atrioventricular Block. JACC Clin Electrophysiol. 2023; 9(9):1977-1986. DOI: 10.1016/j.jacep.2023.05.003. View

Hornberger L, Al Rajaa N . Spectrum of cardiac involvement in neonatal lupus. Scand J Immunol. 2010; 72(3):189-97. DOI: 10.1111/j.1365-3083.2010.02437.x. View

Friedman D, Kim M, Copel J, Llanos C, Davis C, Buyon J . Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study. Am J Cardiol. 2009; 103(8):1102-6. PMC: 2730772. DOI: 10.1016/j.amjcard.2008.12.027. View

10.

Deshpande S, Shenthar J, Khanra D, Isath A, Banavalikar B, Reddy S . Outcomes in congenital and childhood complete atrioventricular block: A meta-analysis. J Cardiovasc Electrophysiol. 2022; 33(3):493-501. DOI: 10.1111/jce.15358. View

11.

Jaeggi E, Hamilton R, Silverman E, Zamora S, Hornberger L . Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution's experience of 30 years. J Am Coll Cardiol. 2002; 39(1):130-7. DOI: 10.1016/s0735-1097(01)01697-7. View

12.

Ciardulli A, DAntonio F, Magro-Malosso E, Manzoli L, Anisman P, Saccone G . Maternal steroid therapy for fetuses with second-degree immune-mediated congenital atrioventricular block: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2018; 97(7):787-794. DOI: 10.1111/aogs.13338. View

13.

Lazzerini P, Capecchi P, Laghi-Pasini F, Boutjdir M . Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias. Nat Rev Cardiol. 2017; 14(9):521-535. DOI: 10.1038/nrcardio.2017.61. View

14.

Alexander M . Success with caution: Forty years of congenital complete atrioventricular block. Heart Rhythm. 2022; 19(7):1156-1157. DOI: 10.1016/j.hrthm.2022.03.1218. View

15.

Steinberg L . Congenital Heart Block. Cardiol Clin. 2023; 41(3):399-410. DOI: 10.1016/j.ccl.2023.03.002. View

16.

Qu Y, Lazzerini P, Capecchi P, Laghi-Pasini F, El Sherif N, Boutjdir M . Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities. Front Cardiovasc Med. 2019; 6:54. PMC: 6507622. DOI: 10.3389/fcvm.2019.00054. View

17.

Kusumoto F, Schoenfeld M, Barrett C, Edgerton J, Ellenbogen K, Gold M . 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice.... J Am Coll Cardiol. 2018; 74(7):932-987. DOI: 10.1016/j.jacc.2018.10.043. View